Director, Osteoporosis Center, Massachusetts General Hospital
Internal Medicine
Dr. Robert M. Neer, MD
|
|
Give Review
Robert Neer practices Internal Medicine. He went to medical school at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical university. Columbia University College of Physicians & Surgeons is ranked 8/52 in Research/PrimaryCare. Robert M. Neer, MD is a published MD. He published 102 publications, including: 'The metabolism of [6-3H]1alpha, hydroxycholecalciferol to [6-3H]1alpha,25-dihydroxycholecalciferol in a patient with renal insufficiency.'
Publications
- Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-H...
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women with Osteoporosis (The DATA Extension Study): a Randomized Controlled Trial.
- Bone loss after bariatric surgery: Discordant results between DXA and QCT bone density.
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.
- Changes in bone resorption across the menopause transition: Effects of reproductive hormones, body size, and ethnicity.
- Differences in Skeletal Microarchitecture and Strength in African-American and Caucasian Women.
- Time-dependent changes in skeletal response to teriparatide: escalating vs. constant dose teriparatide (PTH 1-34) in osteoporotic women.
- Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.
- Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis.
- Effects of teriparatide retreatment in osteoporotic men and women.
- Bone mineral density changes during the menopause transition in a multiethnic cohort of women.
- Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.
- Hormone predictors of bone mineral density changes during the menopausal transition.
- Effects of low-dose prednisone on bone metabolism.
- Glucocorticoid-induced osteoporosis: considerations in ophthalmology.
- Lowering dietary protein to U.S. Recommended dietary allowance levels reduces urinary calcium excretion and bone resorption in young women.
- The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
- Disordered eating, menstrual irregularity, and bone mineral density in female runners.
- Ethnic variation in bone turnover in pre- and early perimenopausal women: effects of anthropometric and lifestyle factors.
- Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors.
- Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.
- Parathyroid hormone induces interleukin-6 gene expression in bone stromal cells of young rats.
- Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis.
- First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip.
- Bone loss across the menopausal transition.
- Multicompartmental analysis of calcium kinetics in normal adult males.
- Body mass index in mid-life women: relative influence of menopause, hormone use, and ethnicity.
- Medical management of the hypercalcemia of malignancy.
- Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity.
- Use of stable 48Ca in the clinical measurement of intestinal calcium absorption.
- Calcium nutrition and bone health in the elderly.
- Vitamin D and bone health in the elderly.
- Parathyroid gland response to epinephrine: a rate-sensitivity mechanism.
- Model for parathyroid hormone secretion and metabolism in calves.
- Protamine: a powerful in vivo inhibitor of bone resorption.
- Current indications for surgery in primary hyperparathyroidism.
- Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.
- Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects.
- Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
- Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
- Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients.
- Skeletal retention of 45Ca and 85Sr compared: further studies on intravenously injected 85Sr as a tracer for skeletal calcium.
- Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting.
- Osteoporosis in women with anorexia nervosa.
- Human parathyroid hormone 1-34-mediated hypercalcemia in a rat model, and its inhibition by dichloromethane diphosphonate.
- Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry.
- Hypogonadism in a male with immunologically active, biologically inactive luteinizing hormone: an exception to a venerable rule.
- Computed tomography scanning for the measurement of bone mineral in the human spine.
- Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
- Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism.
- Lighting for the elderly: a psychobiological approach to lighting.
- Secondary hyperparathyroidism associated with dichloromethane diphosphonate treatment of Paget's disease.
- Gut-mediated hypercalcemia in rabbits bearing VX2 carcinoma: new mechanism for tumor-induced hypercalcemia.
- Father to son transmission of decreased Ns activity in pseudohypoparathyroidism type Ia.
- Kinetic response to dietary calcium changes.
- Effect of sodium fluoride therapy on calcium metabolism in multiple myeloma.
- Dietary perturbation of calcium metabolism in normal man: compartmental analysis.
- Initial fall of plasma calcium after intravenous injection of parathyroid hormone.
- Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma.
- Good light and bad.
- Explanation for unusual potency of salmon calcitonin.
- Thiazides and calcium metabolism.
- Stimulation by artificial lighting of calcium absorption in elderly human subjects.
- An evaluation of antibodies and clinical resistance to salmon calcitonin.
- Pure gonadal dysgenesis with progressive hirsutism.
- Quantitative computed tomography for spinal density measurement. Factors affecting precision.
- Environmental light: effects on vitamin D synthesis and calcium metabolism in humans.
- Osteopenia and bone fractures in a man with anorexia nervosa and hypogonadism.
- Osteoporosis in men with hyperprolactinemic hypogonadism.
- Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine.
- Osteoporosis in men with idiopathic hypogonadotropic hypogonadism.
- Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.
- Inhibition of the in vivo parathyroid hormone-mediated calcemic response in rats by a synthetic hormone antagonist.
- Quantitative digital radiography versus dual photon absorptiometry of the lumbar spine.
- Monoclonal antibodies to bovine parathyroid hormone: production and characterization.
- Changes in serum levels of type I and III procollagen extension peptides during infusion of human parathyroid hormone fragment (1-34).
- Calibration and standardization of bone mineral densitometers.
- Age and bone mass in premenopausal women.
- Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.
- Identification of an antigenic determinant in the amino-terminal sequence of parathyroid hormone.
- Characterization of a high-affinity antiserum specific for the amino-terminal sequence of human parathyroid hormone.
- Effects of transdermal estrogen replacement on parathyroid hormone secretion.
- Effect of season on activity and bone mineral density.
- Lack of evidence for estrogen receptors in human and bovine parathyroid tissue.
- The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass.
- Parathyroid function in normocalcemic renal transplant recipients: evaluation by calcium infusion.
- Pamidronate reduces PTH-mediated bone loss in a gene transfer model of hyperparathyroidism in rats.
- Asymptomatic primary hyperparathyroidism.
- Osteopenia in men with a history of delayed puberty.
- The utility of single-photon absorptiometry and dual-energy x-ray absorptiometry.
- Intermittent administration of bovine PTH-(1-34) increases serum 1,25-dihydroxyvitamin D concentrations and spinal bone density in senile (23 month) rats.
- Calcitriol or calcium for postmenopausal osteoporosis.
- The evolutionary significance of vitamin D, skin pigment, and ultraviolet light.
- Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.
- The metabolism of [6-3H]1alpha, hydroxycholecalciferol to [6-3H]1alpha,25-dihydroxycholecalciferol in a patient with renal insufficiency.
- Hypercalcemia of seven years'' duration after kidney transplantation.
- Hyperparathyroidism during pregnancy.
- Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
- Evaluation of lumber spine bone mineral density (BMD) using dual energy x-ray absorptiometry (DXA) in 21 young men with histories of constitutionally-delayed puberty.
- Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
- Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled T...
Schools
Columbia University College of Physicians And Surgeons
Bronx Municipal Hospital Center
National Institute Htlh
Yale New Haven Hospital
Massachusetts General Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
- Humana
- Medicare MCR
- National Elevator
Education
-
Massachusetts General Hospital -
Yale-New Haven Hospital -
National Institutes of Health Clinical Center -
Albert Einstein College of Medicine at Jacobi Medical Center -
Columbia University College of Physicians & Surgeons
Helpful Reviews
Similar Doctors
|
|
Dr. Sanjay Divakaran, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandra R. Richman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cindy H. Ta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle T. Long, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James P. Roseto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Helen A. Leibner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irwin H. Rosenberg, MD
This Doctor is OpenDoctor Recommended.
|